A common haplotype of the TNF receptor 2 gene modulates endotoxin tolerance

Journal of Immunology

Volumn 186, Issue 5, 2011, Pages 3058-3065

  Fairfax, Benjamin P ^a   Davenport, Emma E ^a   Makino, Seiko ^a   Hill, Adrian V S ^a   Vannberg, Fredrik O ^a   Knight, Julian C ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 2;

ALLELE; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; GENE; GENE EXPRESSION; GENE FUNCTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA INTERACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TNFRSF1B GENE;

ANIMALS; CELLS, CULTURED; COHORT STUDIES; ENDOTOXINS; FEEDBACK, PHYSIOLOGICAL; GENETIC MARKERS; GENOTYPE; HAPLOTYPES; HUMANS; IMMUNE TOLERANCE; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MACACA; PAN TROGLODYTES; POLYMORPHISM, SINGLE NUCLEOTIDE; PONGO; QUANTITATIVE TRAIT LOCI; TNF RECEPTOR-ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79952752358     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1001791     Document Type: Article

References (29)

1. Raetz, C. R., and C. Whitfield. 2002. Lipopolysaccharide endotoxins. Annu. Rev. Biochem. 71: 635-700.
2. Medzhitov, R., P. Preston-Hurlburt, and C. A. Janeway, Jr. 1997. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388: 394-397.
3. Beutler, B., and G. E. Grau. 1993. Tumor necrosis factor in the pathogenesis of infectious diseases. Crit. Care Med. 21(10, Suppl): S423-S435.
4. Van Epps, H. L. 2006. Ignoring endotoxin. J. Exp. Med. 203: 1137.
5. Beeson, P. B.; With the Technical Assistance of Elizabeth Roberts. 1947. Tolerance to Bacterial Pyrogens: I. Factors Influencing Its Development. J. Exp. Med. 86: 29-38.
6. Biswas, S. K., and E. Lopez-Collazo. 2009. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol. 30: 475-487.
7. Sly, L. M., M. J. Rauh, J. Kalesnikoff, C. H. Song, and G. Krystal. 2004. LPS-induced upregulation of SHIP is essential for endotoxin tolerance. Immunity 21: 227-239. (Pubitemid 39094052)
8. van 't Veer, C., P. S. van den Pangaart, M. A. van Zoelen, M. de Kruif, R. S. Birjmohun, E. S. Stroes, A. F. de Vos, and T. van der Poll. 2007. Induction of IRAK-M is associated with lipopolysaccharide tolerance in a human endotoxemia model. J. Immunol. 179: 7110-7120.
9. Baltimore, D., M. P. Boldin, R. M. O'Connell, D. S. Rao, and K. D. Taganov. 2008. MicroRNAs: new regulators of immune cell development and function. Nat. Immunol. 9: 839-845.
10. Bazzoni, F., M. Rossato, M. Fabbri, D. Gaudiosi, M. Mirolo, L. Mori, N. Tamassia, A. Mantovani, M. A. Cassatella, and M. Locati. 2009. Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals. Proc. Natl. Acad. Sci. USA 106: 5282-5287.
11. Foster, S. L., D. C. Hargreaves, and R. Medzhitov. 2007. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447: 972-978. (Pubitemid 46975746)
12. de Craen, A. J., D. Posthuma, E. J. Remarque, A. H. van den Biggelaar, R. G. Westendorp, and D. I. Boomsma. 2005. Heritability estimates of innate immunity: an extended twin study. Genes Immun. 6: 167-170.
13. Fairfax, B. P., F. O. Vannberg, J. Radhakrishnan, H. Hakonarson, B. J. Keating, A. V. Hill, and J. C. Knight. 2010. An integrated expression phenotype mapping approach defines common variants in LEP, ALOX15 and CAPNS1 associated with induction of IL-6. Hum. Mol. Genet. 19: 720-730.
14. Cookson, W., L. Liang, G. Abecasis, M. Moffatt, and M. Lathrop. 2009. Mapping complex disease traits with global gene expression. Nat. Rev. Genet. 10: 184-194.
15. Lettre, G., and J. D. Rioux. 2008. Autoimmune diseases: insights from genomewide association studies. Hum. Mol. Genet. 17(R2): R116-R121.
16. Barrett, J. C., B. Fry, J. Maller, and M. J. Daly. 2005. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
17. Purcell, S., B. Neale, K. Todd-Brown, L. Thomas, M. A. Ferreira, D. Bender, J. Maller, P. Sklar, P. I. de Bakker, M. J. Daly, and P. C. Sham. 2007. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81: 559-575.
18. Schreiber, E., P. Matthias, M. M. Müller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 17: 6419.
19. Udalova, I. A., J. C. Knight, V. Vidal, S. A. Nedospasov, and D. Kwiatkowski. 1998. Complex NF-kappaB interactions at the distal tumor necrosis factor promoter region in human monocytes. J. Biol. Chem. 273: 21178-21186.
20. del Fresno, C., F. García-Rio, V. Gómez-Piña, A. Soares-Schanoski, I. Fernández-Ruíz, T. Jurado, T. Kajiji, C. Shu, E. Marín, A. Gutierrez del Arroyo, et al. 2009. Potent phagocytic activity with impaired antigen presentation identifying lipopolysaccharide- tolerant human monocytes: demonstration in isolated monocytes from cystic fibrosis patients. [Published erratum appears in 2009 J. Immunol. 183: 2194.] J. Immunol. 182: 6494-6507.
21. Keating, B. J., S. Tischfield, S. S. Murray, T. Bhangale, T. S. Price, J. T. Glessner, L. Galver, J. C. Barrett, S. F. Grant, D. N. Farlow, et al. 2008. Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for largescale genomic association studies. PLoS ONE 3: e3583.
22. Keen, L., N. Wood, O. Olomolaiye, and J. Bidwell. 1999. A bi-allelic VNTR in the human TNFR2 (p75) gene promoter. Genes Immun. 1: 164-165.
23. Lee, Y. H., Y. H. Rho, S. J. Choi, J. D. Ji, and G. G. Song. 2003. The biallelic variable number of tandem repeats of the tumor necrosis factor receptor 2 promoter in systemic lupus erythematosus. Rheumatol. Int. 23: 108-111.
24. Sainz, J., E. Pérez, L. Hassan, A. Moratalla, A. Romero, M. D. Collado, and M. Jurado. 2007. Variable number of tandem repeats of TNF receptor type 2 promoter as genetic biomarker of susceptibility to develop invasive pulmonary aspergillosis. Hum. Immunol. 68: 41-50.
25. Bell, J. H., A. H. Herrera, Y. Li, and B. Walcheck. 2007. Role of ADAM17 in the ectodomain shedding of TNF-alpha and its receptors by neutrophils and macrophages. J. Leukoc. Biol. 82: 173-176.
26. Horiuchi, K., T. Kimura, T. Miyamoto, H. Takaishi, Y. Okada, Y. Toyama, and C. P. Blobel. 2007. Cutting edge: TNF-alpha-converting enzyme (TACE/ ADAM17) inactivation in mouse myeloid cells prevents lethality from endotoxin shock. J. Immunol. 179: 2686-2689.
27. Grell, M., E. Douni, H. Wajant, M. Löhden, M. Clauss, B. Maxeiner, S. Georgopoulos, W. Lesslauer, G. Kollias, K. Pfizenmaier, and P. Scheurich. 1995. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83: 793-802.
28. Ban, L., J. Zhang, L.Wang, W. Kuhtreiber, D. Burger, and D. L. Faustman. 2008. Selective death of autoreactive T cells in human diabetes by TNF or TNF receptor 2 agonism. Proc. Natl. Acad. Sci. USA 105: 13644-13649.
29. Westendorp, R. G., J. A. Langermans, T. W. Huizinga, A. H. Elouali, C. L. Verweij, D. I. Boomsma, and J. P. Vandenbroucke. 1997. Genetic influence on cytokine production and fatal meningococcal disease. [Published erratum appears in 1997 Lancet 349: 646.] Lancet 349: 170-173. (Pubitemid 27039197)